Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2025 Earnings Call Transcript February 11, 2026 Viking Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.38 EPS, expectations were $-0.

Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator ...

Atossa Therapeutics, Inc. ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet need, today issued a letter to ...

F1 returns this week with pre-season testing. Here’s what to expect ...

Market valued at $16.86B in 2024, projected 4.20% CAGR growth driven by VOC regulation compliance, bio-based adoption, ...

Experience Efficient and Flexible Scanning Solutions with Canon’s New imageFORMULA R40II Office Document Scanner ...

Q4 2025 Earnings Call February 11, 2026 7:30 AM ESTCompany ParticipantsCiaran Potts - Head of Investor RelationsAnthony P. J.

F1’s 2026 season inches closer this week as teams descend on Bahrain International Circuit for the first official pre-season test. […] ...

A naturally aspirated V6 engine, rear-wheel drive, and enthusiast focus, available for the price of a new family sedan.

October, the company announced that it is withdrawing the financial targets communicated on 1 June 2022. The targets are currently under revision ...

Rivian has spent the past few years proving that electric trucks can be credible adventure machines, but its latest off-road pickup adds a twist that pushes the segment into new territory. Instead of ...

Premium cotton sheets that might cost $80 or more elsewhere can often be found for $25-30, allowing Iowa households to enjoy ...